Related Experiment Video
Updated: Apr 28, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Multisystem inflammatory syndrome in children (MIS-C), United States, 2023-2024
Ami B Shah1,2, Katherine N Lindsey1,3, Laura D Zambrano1
1Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract:
Multisystem inflammatory syndrome in children (MIS-C) is rare following SARS-CoV-2 infection, but sporadic cases continue to be reported. This analysis of cases from 2023-2024 shows little change in clinical presentation between years. Among vaccine age-eligible children, 99% of cases occurred in children who were not up-to-date with COVID-19 vaccination.
Related Concept Videos
Multiple Sclerosis l: Introduction
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Investigation of Disease Outbreaks
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Viral Meningitis
